134 related articles for article (PubMed ID: 8824287)
1. JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes.
Gómez del Arco P; Martínez-Martínez S; Calvo V; Armesilla AL; Redondo JM
J Biol Chem; 1996 Oct; 271(42):26335-40. PubMed ID: 8824287
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of endothelial cells by the antioxidant pyrrolidine dithiocarbamate: involvement of C-jun N-terminal kinase and AP-1 activation.
Liao HL; Zhu Y; Wang N; Verna L; Stemerman MB
Endothelium; 2000; 7(2):121-33. PubMed ID: 10865940
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
[TBL] [Abstract][Full Text] [Related]
4. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation.
Faris M; Kokot N; Lee L; Nel AE
J Biol Chem; 1996 Nov; 271(44):27366-73. PubMed ID: 8910314
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells.
Min YK; Park JH; Chong SA; Kim YS; Ahn YS; Seo JT; Bae YS; Chung KC
J Neurosci Res; 2003 Mar; 71(5):689-700. PubMed ID: 12584727
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase.
Zohn IE; Yu H; Li X; Cox AD; Earp HS
Mol Cell Biol; 1995 Nov; 15(11):6160-8. PubMed ID: 7565768
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1.
Humar M; Andriopoulos N; Pischke SE; Loop T; Schmidt R; Hoetzel A; Roesslein M; Pahl HL; Geiger KK; Pannen BH
J Pharmacol Exp Ther; 2004 Dec; 311(3):1232-40. PubMed ID: 15263067
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells.
Zhang J; Salojin KV; Gao JX; Cameron MJ; Bergerot I; Delovitch TL
J Immunol; 1999 Apr; 162(7):3819-29. PubMed ID: 10201899
[TBL] [Abstract][Full Text] [Related]
10. Activation of ERK and JNK1 MAP kinases in cultured lung tissue.
Shapiro P; Absher PM; Posada JP; Evans JN
Am J Physiol; 1997 Aug; 273(2 Pt 1):L459-67. PubMed ID: 9277460
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis.
Shrivastava A; Aggarwal BB
Antioxid Redox Signal; 1999; 1(2):181-91. PubMed ID: 11228746
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
13. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.
DeSilva DR; Feeser WS; Tancula EJ; Scherle PA
J Exp Med; 1996 May; 183(5):2017-23. PubMed ID: 8642312
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
15. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis.
Lenczowski JM; Dominguez L; Eder AM; King LB; Zacharchuk CM; Ashwell JD
Mol Cell Biol; 1997 Jan; 17(1):170-81. PubMed ID: 8972197
[TBL] [Abstract][Full Text] [Related]
16. Dual activity of pyrrolidine dithiocarbamate on kappaB-dependent gene expression in U937 cells: II. Regulation by tumour necrosis factor-alpha.
Watanabe K; Kazakova I; Furniss M; Miller SC
Cell Signal; 1999 May; 11(5):371-83. PubMed ID: 10376811
[TBL] [Abstract][Full Text] [Related]
17. Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells.
Jung S; Yaron A; Alkalay I; Hatzubai A; Avraham A; Ben-Neriah Y
Ann N Y Acad Sci; 1995 Sep; 766():245-52. PubMed ID: 7486667
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway.
Yokoo T; Kitamura M
Am J Physiol; 1996 May; 270(5 Pt 2):F806-11. PubMed ID: 8928842
[TBL] [Abstract][Full Text] [Related]
19. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase.
Westwick JK; Weitzel C; Minden A; Karin M; Brenner DA
J Biol Chem; 1994 Oct; 269(42):26396-401. PubMed ID: 7929360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
